BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17147794)

  • 21. Cherubism allele heterozygosity amplifies microbe-induced inflammatory responses in murine macrophages.
    Prod'Homme V; Boyer L; Dubois N; Mallavialle A; Munro P; Mouska X; Coste I; Rottapel R; Tartare-Deckert S; Deckert M
    J Clin Invest; 2015 Apr; 125(4):1396-400. PubMed ID: 25705883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SH3BP2 is rarely mutated in exon 9 in giant cell lesions outside cherubism.
    Lietman SA; Prescott NL; Hicks DG; Westra WH; Levine MA
    Clin Orthop Relat Res; 2007 Jun; 459():22-7. PubMed ID: 17545756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pro416Arg cherubism mutation in Sh3bp2 knock-in mice affects osteoblasts and alters bone mineral and matrix properties.
    Wang CJ; Chen IP; Koczon-Jaremko B; Boskey AL; Ueki Y; Kuhn L; Reichenberger EJ
    Bone; 2010 May; 46(5):1306-15. PubMed ID: 20117257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathologic and Molecular Characteristics of Familial Cherubism with Associated Odontogenic Tumorous Proliferations.
    Argyris PP; Gopalakrishnan R; Hu Y; Reichenberger EJ; Koutlas IG
    Head Neck Pathol; 2018 Mar; 12(1):136-144. PubMed ID: 28721660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a Norwegian cherubism cohort; molecular genetic findings, oral manifestations and quality of life.
    Prescott T; Redfors M; Rustad CF; Eiklid KL; Geirdal AØ; Storhaug K; Jensen JL
    Eur J Med Genet; 2013 Mar; 56(3):131-7. PubMed ID: 23298620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cherubism as a systemic skeletal disease: evidence from an aggressive case.
    Morice A; Joly A; Ricquebourg M; Maruani G; Durand E; Galmiche L; Amiel J; Vial Y; Cavé H; Belhous K; Piketty M; Cohen-Solal M; Berdal A; Collet C; Picard A; Coudert AE; Kadlub N
    BMC Musculoskelet Disord; 2020 Aug; 21(1):564. PubMed ID: 32825821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cherubism: a case report.
    Dincă O; Severin E; Vlădan C; Bodnar DC; Bucur A
    Rom J Morphol Embryol; 2014; 55(2 Suppl):655-8. PubMed ID: 25178340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA analysis of the SH3BP2 gene in patients with aggressive central giant cell granuloma.
    de Lange J; van Maarle MC; van den Akker HP; Redeker EJ
    Br J Oral Maxillofac Surg; 2007 Sep; 45(6):499-500. PubMed ID: 16713042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of SH3BP2 in the pathophysiology of cherubism.
    Reichenberger EJ; Levine MA; Olsen BR; Papadaki ME; Lietman SA
    Orphanet J Rare Dis; 2012 May; 7 Suppl 1(Suppl 1):S5. PubMed ID: 22640988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [SH3BP2 heterozygous mutation amplifies macrophage inflammatory responses to infection in a mouse model of cherubism].
    Deckert M; Prod'Homme V
    Med Sci (Paris); 2015; 31(6-7):589-91. PubMed ID: 26152156
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification and characterization of the human homologue of SH3BP2, an SH3 binding domain protein within a common region of deletion at 4p16.3 involved in bladder cancer.
    Bell SM; Shaw M; Jou YS; Myers RM; Knowles MA
    Genomics; 1997 Sep; 44(2):163-70. PubMed ID: 9299232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cherubism].
    Brix M; Peters H; Lebeau J
    Rev Stomatol Chir Maxillofac; 2009 Nov; 110(5):293-8. PubMed ID: 19836038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Molecular and Cellular Pathogenesis of Cherubism].
    Ueki Y
    Clin Calcium; 2016 Jun; 26(6):918-26. PubMed ID: 27230848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial cherubism: clinical and radiological features. Case report and review of the literature.
    Sidorowicz W; Kubasiewicz-Ross P; Dominiak M
    Eur J Paediatr Dent; 2018 Sep; 19(3):213-217. PubMed ID: 30063153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Gene mutation and expression of SH-3BP-2 in cherubism].
    Li YW; Meng XM; Yu SF; Gao P
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Apr; 44(4):227-31. PubMed ID: 19576004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cherubism - new hypotheses on pathogenesis and therapeutic consequences.
    Hyckel P; Berndt A; Schleier P; Clement JH; Beensen V; Peters H; Kosmehl H
    J Craniomaxillofac Surg; 2005 Feb; 33(1):61-8. PubMed ID: 15694152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cherubism: a systematic literature review of clinical and molecular aspects.
    Chrcanovic BR; Guimarães LM; Gomes CC; Gomez RS
    Int J Oral Maxillofac Surg; 2021 Jan; 50(1):43-53. PubMed ID: 32620450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Jawing about TNF: new hope for cherubism.
    Novack DV; Faccio R
    Cell; 2007 Jan; 128(1):15-7. PubMed ID: 17218248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cherubism gene Sh3bp2 is important for optimal bone formation, osteoblast differentiation, and function.
    Mukherjee PM; Wang CJ; Chen IP; Jafarov T; Olsen BR; Ueki Y; Reichenberger EJ
    Am J Orthod Dentofacial Orthop; 2010 Aug; 138(2):140.e1-140.e11; discussion 140-1. PubMed ID: 20691350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-tumor necrosis factor treatment in cherubism--clinical, radiological and histological findings in two children.
    Hero M; Suomalainen A; Hagström J; Stoor P; Kontio R; Alapulli H; Arte S; Toiviainen-Salo S; Lahdenne P; Mäkitie O
    Bone; 2013 Jan; 52(1):347-53. PubMed ID: 23069372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.